Opendata, web and dolomites

ORBIS SIGNED

Open Research Biopharmaceutical Internships Support

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ORBIS project word cloud

Explore the words cloud of the ORBIS project. It provides you a very rough idea of what is the project "ORBIS" about.

environment    ukraine    physical    inter    chemistry    industrial    bioanalytical    beneficiaries    germany    computations    membrane    overarching    molecules    ireland    action    biopharmaceutical    outcomes    network    scientists    academia    sectoral    cooperation    exchange    productivity    preclinical    skills    drug    industry    integrate    career    dissolution    concentrating    approximately    pharmaceutical    market    accessible    formulations    soft    amalgamate    fill    complementary    rate    society    multidisciplinary    medicines    demanded    permeability    candidates    public    republic    individual    stimulating    links    proposes    create    20    orbis    oral    expertise    secondments    classification    class    international    czech    lengthy    bioanalysis    nanotechnology    synthesis    science    stage    material    affordable    consolidate    poor    70    biopharmaceutics    pharmacy    poland    pharmacology    attrition    solubility    academic    enters    drugs    inefficient    internships    bioavailability    gap    dermal    technologies    experts    finland    actives    medicine    country    form   

Project "ORBIS" data sheet

The following table provides information about the project.

Coordinator
UNIWERSYTET MEDYCZNY IM KAROLA MARCINKOWSKIEGO W POZNANIU 

Organization address
address: UL. FREDRY 10
city: POZNAN
postcode: 61-701
website: www.ump.edu.pl

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Poland [PL]
 Total cost 2˙268˙000 €
 EC max contribution 2˙268˙000 € (100%)
 Programme 1. H2020-EU.1.3.3. (Stimulating innovation by means of cross-fertilisation of knowledge)
 Code Call H2020-MSCA-RISE-2017
 Funding Scheme MSCA-RISE
 Starting year 2018
 Duration (year-month-day) from 2018-03-01   to  2022-02-28

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIWERSYTET MEDYCZNY IM KAROLA MARCINKOWSKIEGO W POZNANIU PL (POZNAN) coordinator 684˙000.00
2    POLITECHNIKA POZNANSKA PL (POZNAN) participant 369˙000.00
3    JOINT STOCK COMPANY FARMAK UA (KIJEV) participant 315˙000.00
4    SIEC BADAWCZA LUKASIEWICZ - INSTYTUT FARMACEUTYCZNY PL (WARSZAWA) participant 274˙500.00
5    ZENTIVA, K.S. CZ (Prague) participant 270˙000.00
6    HELSINGIN YLIOPISTO FI (HELSINGIN YLIOPISTO) participant 171˙000.00
7    THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN IE (DUBLIN) participant 112˙500.00
8    PHYSIOLUTION GMBH DE (GREIFSWALD) participant 45˙000.00
9    APPLIED PROCESS COMPANY LIMITED IE (DUBLIN) participant 27˙000.00
10    RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY US (NEW BRUNSWICK) partner 0.00

Map

 Project objective

The current process of drug development is lengthy and inefficient. Only 1 out of approximately 10,000 drug molecules enters the market. Therefore more effective medicines, demanded by society, cannot be provided by pharmaceutical industry. To fill this gap, Open Research Biopharmaceutical Internships Support (ORBIS) proposes that the high attrition rate of new drug candidates might be reduced by over 20% by improving early stage R&D productivity. The overarching objective of ORBIS is therefore to form an international and inter-sectoral academic and industrial network. The action is aimed at improving the preclinical pathway of medicine development concentrating on processes and technologies. The goal is to integrate multidisciplinary research by involving academia and industry from EU (Poland, Ireland, Finland, Germany and Czech Republic), EU associated country (Ukraine) and US to address the poor drug bioavailability as 70% of actives have solubility and/or membrane permeability problems. The action is addressed at selected molecules of class II and IV of Biopharmaceutics Classification System, to improve their pharmaceutical potential. The complementary consortium comprises experts in computations, physical chemistry, material science, nanotechnology, pharmacy, pharmacology and bioanalysis. The secondments will create a stimulating environment for early stage researchers to advance their individual career and soft skills. EU scientists will amalgamate their expertise in drug synthesis and dissolution, oral formulations, and bioanalytical methods with the knowledge on dermal research provided by the US partner. ORBIS will consolidate the existing links, promote long-term cooperation and exchange of knowledge between beneficiaries and partners. ORBIS will also enhance dissemination of new research outcomes and raise the awareness among the general public of the importance of drug delivery research that makes new drugs more accessible and affordable for society.

 Deliverables

List of deliverables.
Mid-term meeting. Other 2020-01-14 15:07:29
Workshop on dosage forms and drug delivery systems. Other 2019-10-15 13:13:56
2nd School on oral dosage and drug delivery systems. Other 2019-10-15 13:14:08
1st School on pharmaceutical preformulation testing of APIs and dosage forms. Other 2019-10-15 12:11:42
Open Workshop on process development of drug substances. Other 2019-10-15 12:11:42
Kick-off meeting. Other 2019-10-15 12:11:42
ORBIS website launched + Social media channels established. Websites, patent fillings, videos etc. 2019-10-15 12:11:42

Take a look to the deliverables list in detail:  detailed list of ORBIS deliverables.

 Publications

year authors and title journal last update
List of publications.
2019 Piotr J. Rudzki, Przemysław Biecek, Michał Kaza
Incurred Sample Reanalysis: Time to Change the Sample Size Calculation?
published pages: , ISSN: 1550-7416, DOI: 10.1208/s12248-019-0293-2
The AAPS Journal 21/2 2019-10-15

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ORBIS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ORBIS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.3.)

CONMECH (2019)

Nonsmooth Contact Dynamics

Read More  

VIDEC (2020)

Visualizing Death Inducing Protein Complexes

Read More  

NEW MARKETS (2019)

New Market: an exploration into the changing nature of business environments, informal barriers and emerging markets in the post-Soviet region

Read More